Kimberly Sieren Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 23347 Royal Oaks Trl, Kirksville, MO 63501 Phone: 660-627-3612 |
Elizabeth C Lawinger, MOTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2814 S Baltimore St, Kirksville, MO 63501 Phone: 660-785-1834 Fax: 660-785-1825 |
Melissa A Brown, OTR/L, PTA Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2814 S Baltimore St, Kirksville, MO 63501 Phone: 660-785-1834 Fax: 660-785-1825 |
Mr. David Paul Mclain, MOTR/L Occupational Therapist Medicare: Accepting Medicare Assignments Practice Location: 2814 S Baltimore St, Kirksville, MO 63501 Phone: 660-785-1834 Fax: 660-785-1825 |
Mrs. Stacie K. Hudson, OTR/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1901 E Hamilton St, Kirksville, MO 63501 Phone: 660-626-1400 Fax: 660-665-3281 |
Angelynn Rose Zimmerman, ORT/L Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 2814 S Baltimore St, Kirksville, MO 63501 Phone: 660-785-1834 |
Ms. Krista K Snow, M.S. Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1901 E Hamilton St, Kirksville, MO 63501 Phone: 660-626-1400 Fax: 660-665-3281 |
Mrs. Kristen Suzanne Gillette, OTR/L, DPT Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1901 E Hamilton St, Kirksville, MO 63501 Phone: 660-626-1400 Fax: 660-665-3281 |
Mr. Jeffery Silvernail Occupational Therapist Medicare: Not Enrolled in Medicare Practice Location: 1901 E Hamilton St, Kirksville, MO 63501 Phone: 660-626-1400 Fax: 660-665-3281 |
News Archive
Transition Therapeutics Inc. ("Transition" or the "Company") today announced findings from a Phase 2 study of neuropsychiatric drug candidate, ELND005, as an adjunctive maintenance treatment for bipolar disorder type I patients (BPD).
Advanced Cell Technology, Inc., a biotechnology company applying cellular technology in the field of regenerative medicine, announced today that it has received notification from the US Food and Drug Administration (FDA) that the Agency is currently drafting a response to the Company relating to the Investigational New Drug (IND) Application it filed in November seeking clearance to initiate a Phase I/II multicenter study using embryonic stem cell derived retinal cells to treat patients with Stargardt's Macular Dystrophy (SMD).
Secretary of State Hillary Rodham Clinton on Tuesday voiced her "support for the inclusion of women's issues on the agenda of the G20 Seoul Summit slated for Thursday and Friday in a video message to a parliamentary seminar" on the issue held in Korea, the Korea Times reports.
The virtual Iraq simulation, developed at the University of Southern California (USC) but now being put into practice at Reading, is "fully-immersive" and designed as part of an exposure therapy programme which allows soldiers suffering post-traumatic stress disorder to relive and confront psychological trauma - and it has produced promising results for the first handful of patients treated.
› Verified 4 days ago